https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/statements/statement-older-people-are-at-highest-risk-from-covid-19,-but-all-must-act-to-prevent-community-spread

Thanks Mutasem Z. Bani-Fwaz for your interest in the topic and the valued link you shared.

Really, such a case is very critical as indicated in the WHO daily reports...

As other dieases those are open place

Thanks Emad Kamil Hussein and Suhad Mohammed for their useful comments.

Fatality

The outcome is developing the adaptive lmmunity or acquired immunity which is developed from exposure to an infection or disease such as COVID-19.

Thanks Huda Hadi Al-Hasnawy and Abdulridha Sarhan for sharing your personal views.

Severe COVID-19 disease and high rate of fatality

Dear Ahmad Zia Noori thanks for your valued response. Your comment is logical and appreciable.

Immunocompromised patients seem to have typical clinical manifestations of COVID-19. Patients with cancer and solid organ transplant (SOT) recipients may be at higher risk for more severe COVID-19 disease.

This is the worst case of a comorbid condition. So far, there are few methods of managing such patients. The mortality rate is extremely high.

Regards, Sergey Viktorovich Pushkin

follow

https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/immunocompromised.html

Dear Sergey Viktorovich Pushkin thanks for your valued contribution. I appreciate your viewpoint.

Dear Tuqa Abdul Kareem Hameed thanks for your interest in the topic.

Dear Suhad Mohammed thanks for sharing the useful link. I appreciate your effort.

I think these cases would have a mortality rate

Lamia Mustafa Al-Naama, thanks for your valued response. You are welcome.

Take a look at this useful link.

https://www.aidsmap.com/about-hiv/covid-19-and-coronavirus-people-living-hiv

Arvind Singh, thanks for sharing the link. Certainly, I will go through it. I appreciate your efforts.

I agree with Abdulridha Sarhan